5Maschio G, Alberti D, Janin G, et al. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med, 1996,334:939-945.
6Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure inproteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia). Lancet, 1997,349:1857-1863.
7Levy D, Anderson KM, Savage DD, et al. Echocardiographically detected left ventficular hypertrophy: prevalence and risk factors.The Framingham Heart Study. Ann Intern Med, 1988,108:7-13.
8Stein G, Busch M, Muller A, et al. Are advanced glycation end products cardiovascular risk factors in patients with CRF? Am J Kidney Dis,2003,41 (3 Suppl 1 ) :S52-S56.
9Peterson JC, Adler S, Burkart JM, et al. Blood pressure control,proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study. Ann Intern Med, 1995,123:754-762.
10Woo KT, Lau YK, Wong KS,et al. ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in lgA nephritis.Kidney Int, 2000,58:2485-2491.
